BROADENING HOST RANGE IN A GLOBALIZING WORLD Monkeypox virus emergence and threat

Similar documents
OUR COMMUNITY: OUR WORLD: ONE HEALTH. Ebola : Geomedicine Conference

HIBA ABDALRAHIM Capsca Focal Point Public Health Authority

UTSW/BioTel EMS TRAINING BULLETIN October EMS TB Ebola Virus Disease (EVD)

Questions and Answers on Ebola

Global Catastrophic Biological Risks

Ebola Virus Disease. Global Epidemiology and Surveillance in Hong Kong. as of 13 August 2014

World Health Organization Department of Communicable Disease Surveillance and Response

Summary of current outbreak in Guinea, Liberia and Sierra Leone

EDUCATIONAL COMMENTARY EMERGING INFECTIOUS DISEASES WITH GLOBAL IMPACT

Genus Ebolavirus is 1 of 3 members of the Filoviridae family (filovirus), along with genus Marburgvirus and genus Cuevavirus.

EBOLA. Harford County Health Department October 22, 2014

Where is the frontline in the battle against infectious diseases?

Media centre Ebola virus disease

Ebola Virus Patient Advisory

Making Sense Of The Ebola Virus

OIE Situation Report for Highly Pathogenic Avian Influenza

Yellow fever. Key facts

ANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA

The Ebola Virus. By Emilio Saavedra

Digital Disease Detection: MERS, Ebola, and Measles. Maimuna S. Majumder

RAM U S. D E P A R T M E N T O F H E A L T H. E D U C A T IO N. AND W E LF A R E. J u l y 1970

Specific issues related to FMD surveillance in the eastern Africa sub-region. Gideon Brückner

Identifying, Preparing for & Reducing Pandemic Risk

Public Health Management and Preparedness in Wildlife Zoonotic Disease Outbreak

Yellow fever laboratory capacity on-site assessments in Africa: preliminary findings

Ebola Virus Disease: the Facts, Response & the Way Forward. Dr. Abraham Idokoko Ebola Emergency Operations Centre (EEOC), Lagos.

Prioritizing Emergency Polio Eradication Activities

Ebola Epidemic in Coastal West Africa Overall Situation

Vol. 5 Issue 2, 31 May 2015

Monkeypox was a surprise but shouldn t have been, considering the risks of keeping exotic animals or native wildlife as pets.

Mathematical modeling of cholera

OIE Situation Report for Avian Influenza

THE UNREGULATED AND INFORMAL TRADE IN WILDLIFE: IMPLICATIONS FOR BIODIVERSITY AND HEALTH

Better Training for Safer Food BTSF

OIE Situation Report for Avian Influenza

Viral Hemorrhagic Fevers

Ebola Virus Disease (EVD) Essential information

Global Polio Eradication, Progress, Impact of Ebola, Risks & Opportunities. Polio Partners Group 8 December 2014

OIE Situation Report for Highly Pathogenic Avian Influenza

EBOLA VIRUS DISEASE. Democratic Republic of Congo. External Situation Report 1. Credit : B.Sensasi / WHO Uganda-2007

Countries initially targeted: Bangladesh, Mongolia, Myanmar, Nepal, Lao People s Demoncratic Republic and Pakistan.

OIE Situation Report for Highly Pathogenic Avian Influenza

POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY

Global and Regional update on Polio Eradication Activities. Kenya Paediatric Association Pride Inn, Mombasa April 26, 2018

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

David L. Suarez D.V.M., PhD. A.C.V.M.

Evaluating the promise of a transmissible vaccine. Scott L. Nuismer

Image of Ebola viruses exiting host cells HUMAN VIRUSES & THE LIMITATION OF ANTIVIRAL DRUG AGENTS

Scientific Opinion on sheep pox and goat pox - first part

Case study: Epidemic modelling in real life

Trends of Pandemics in the 21 st Century

Innovation in Medicine

THE ROLE OF THE HUMAN/ANIMAL INTERFACE IN THE ZOONOSES

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012

Francine Ntoumi PhD, HDR, FRCP Coordinator Fondation Congolaise pour la Recherche Medicale, Brazzaville, Congo

Ebola Virus Disease(EVD)

OIE Situation Report for Avian Influenza

CIRCULAR LETTER No

Rapid Missions Update Animal Health Emergencies

EBOLA VIRUS DISEASE. Democratic Republic of Congo. External Situation Report 2. Credit : B.Sensasi / WHO Uganda-2007

Experiences on Workforce Development in Other Regions

FRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat

UNICEF s Response to the Ebola Crisis. Presenta(on to the Execu(ve Board, Informal Session, 11 September 2014

Events detected by national surveillance system (see Annex 1)

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

Communicable diseases. Gastrointestinal track infection. Sarkhell Araz MSc. Public health/epidemiology

EBOLA & OTHER VIRUSES IN THE NEWS EBOLA VIRUS, CHIKUNGUNYA VIRUS, & ENTEROVIRUS D68

PESTES DES PETITS RUMINANTS

EBOLA INFORMATION KIT 20 to 26 October 2014 MEMBERS NEWS HUNTING SERVICES FUND LEGISLATION CALENDAR GENERAL SHOP POPULAR ARTICLES

VPD in Mediterranean Basin and Black Sea: the Polio case

Ebola Epidemic. The largest epidemic of Ebola virus disease (EVD) was experienced between December 2013

Relations between pathogens, hosts and environment: joining up the dots

PRESENT PROBLEMS OF YELLOW FEVER IN AFRICA. (Report by the Director-General)

GF-TADs for Europe. Presentation of the RSC6 outcomes and implementation of the RSC6 and first Action Plan. AFSCA - Brussels October 2017

OIE Situation Report for Avian Influenza

Key Points Ebola Virus Disease, West Africa Newly updated information is indicated in red

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine

The Threat of Agroterrorism and Zoonotic Diseases in the United States

Wild Poliovirus Weekly Update

Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union

'Conflict in new Ebola zone of DR Congo exacerbates complexity of response' Dimanche, 05 Août :22 - Mis à jour Dimanche, 05 Août :24

DEFINING PANDEMIC. Dr Wan Noraini Wan Mohamed Noor Head of Surveillance Sector Disease Control Division, MOH Malaysia 3 May 2018

Center for Global Health. CDC Global Health Saving Lives Overseas, Protecting Americans at Home

Rift Valley Fever in Saudi Arabia Current Status. Presented by: Bayoumi, F. A. Director of Animal Health Branch Ministry of Agriculture, KSA

OIE Situation Report for Avian Influenza

OUTLINE INTRODUCTION 10/17/2011. Introduction Current Knowledge Future Directions

Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared?

Epidemic Ebola Virus Disease Understanding, demystifying and controlling a frightening disease Republic of Guinea, 2014

Rift Valley Fever. What is Rift Valley Fever?

U.S. and British troops head to West Africa to help fight Ebola virus

COMPLETE ALL QUESTIONS AND MARGIN NOTES

Suggested Exercises and Projects 395

Viruses: Select Agents and Emerging Pathogens. Patricia Bolívar MS., CLS, PHM

Outline. Introduction to Epidemiology. Epidemiology. Epidemiology. History of epidemiology

The Struggle with Infectious Disease. Lecture 5

SYMPOSIUM 2: COMMUNICABLE DISEASES

Assessing economic vulnerability to emerging infectious disease outbreaks: Ebola versus Zika

Drivers of Infectious Disease: Connections Matter

EBOLA VIRUS DISEASE. Page 1

Transcription:

BROADENING HOST RANGE IN A GLOBALIZING WORLD Monkeypox virus emergence and threat Laudisoit Anne*, Gryseels Sophie, Mussaw Moise, Rouquette Olivier, Van Houtte Natalie, Musaba Prescott, Chantrey Julian, Begon Mike, Muyembe Jean Jacques, Leirs Herwig and Verheyen Erik *anne.laudisoit@liverpool.ac.uk

THE ERADICATION OF SMALLPOX : A WHO SUCCESS STORY 18th century : EUROPE 1/10 children died of smallpox 1950 50 million infections in the world 1977 Last natural infection 1979 Laboratory infection 33 endemic countries 1200 millions people 2 million deaths 1967 START eradication campaign 8th May 1980 ERADICATION TOTAL COST: 320 m$ SAR 80% CFR 25-40% R 0 3.5-6.9 How was it possible? VACCINE AVAILABLE VACCINEES IDENTIFIABLE VACCINEES VACCINATING MANPOWER - FUNDS NO ANIMAL RESERVOIR No renewable source

The EMERGENCE OF MONKEYPOX : A VIRAL SUCCESS STORY N annual cases/total (1996-2010) 1958 captive primates 1980 Active disease surveillance 1980-1986 338 cases Cessation of surveillance 2005-2007 Active surveillance 760 cases 1970 First human DRC 1971 Three West African countries 1985 Isolation from squirrel 20-fold increase 1996-1997 OUTBREAK 511 cases N COUNTRIES PERIOD N 1 Cameroon 1976-1990 24 2 Central African Republic 1984 6 3 Democratic Republic of Congo Endemic 4 Gabon 1987-1991 35 5 Ivory Coast 1971-1981 11 6 Liberia 1970 4 7 Nigeria 1971-1978 21 8 Republic of Congo Sporadic 9 Sierra Leone 1970-2014 11 10 Sudan 2005 19 0,25 0,2 0,15 0,1 0,05 14263Cases 243 HZ 0 1995 2000 2005 2010

MONKEYPOX VIRUS AND HOST RANGE RESERVOIRS OR NOT? THAT S THE QUESTION Species Confirmed human HMPX 4/4 (100) Rodents Cricetomys emini 2/7 (29) HA PCR positives/total (%) 40 Genus at least 65 species screened OXP-PCR : 137/462 = 29,7% INFECTED (DNA evidence) MKX-PCR : 12/108 = 11.1% INFECTED (DNA evidence) BROAD HOST TROPISM No difference between left and right bank WA-clade Sporadic case no interhuman transmission CB-clade Epidemic : interhuman transmission, increased virulence

MULTIPLE HOSTS AGENTS THE challenge to EID control 77% of livestock pathogens 91% of domestic carnivore pathogens 81.4% of animal diseases of greatest international importance infect multiple wildlife hosts The ability of pathogens to infect a wide range of hosts 1) is a risk factor for disease emergence 2) is key to eradication probability linked to hosts number, identity and ethology 3) requires more than presence/absence data transmission and contamination pathways spatial and temporal series cfr population dynamics interspecific network of interactions (camera trapping/behavior) frequency of inter- and intra-specific contacts evolution of agent-specific immunity

THE AGENT vs THE HOSTs POPULATIONs IMMUNE STATUS THE challenge to understanding disease dynamics R0 is NOT an intrinsic property of the infectious agent!!! Epidemic/Epizootic characteristic Virulence infectious agent (t x ) individual immune status herd-immunity R 0 for human MPX =? (based on few data : 0.83 to 1) Anybody knowing 1) R 0 for his/her «favorite agent» in WILD ANIMAL POPULATIONS? 2) the individual level of hosts immunity in target population(s)?

ASSESSING EPIDEMIC and EPIZOOTIC THREAT Does the agent portend pandemic/zootic potential? YOU ARE HERE EID do not respect borders, hide in suitcases, in multiple hosts EMERGENCE FROM LMIC without AFSCA -like controls BRIBE OR RACIAL PROFILING AT ENTRY / EXIT LMIC POINTS From a village in the heart of Africa to Brussels or...chicago IMPACT : 11/06/2003 Prohibition of all African rodents import into the USA (CDC) and sale, distribution, transport, or release ban of prairie dogs and six specific genera of African rodents within the USA (FDA).

Key points to discuss in a ONE HEALTH CONTEXT R&D «Prevention Preparedness Response» Research & Development (R&D) 1) VIRUS : WHY SUCH A BROAD HOST RANGE? Evolution towards human pathogenicity of Orthopoxviruses 2) WHAT ABOUT MPXV in domestic animals in DRC? In Africa? 3) HUMAN POPULATIONS : SPORADIC VS EPIDEMICS Disease dynamics and immunity VS source, mode and strain influence on R 0? Are the recovered hosts immune for life? Need a better surveillance - case notification and RDT in the field VACCINE DEVELOPMENT?! Coordinated «Prevention Preparedness Response» (PPR) We CANNOT wait the (next) big epidemics/zootics to hit the fan! What if shit happens? Example : Ebola outbreak Urge for a ONE HEALTH coordinated approach at ALL levels!!!